NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction

References

• Lax I, Blomgren H, Näslund I, Svanström R. Stereotactic radiotherapy of malignancies in the abdomen – methodological aspects. Acta Oncol 1994;33:677–83.
   PubMed Web of Science ®Google Scholar
• Lax I, Larsson D, Näslund I. Extracranial stereotactic radiosurgery of localized targets. J Radiosurg 1998;1:135–48.
   Google Scholar
• Blomgren H, Lax I, Näslund I, Svanström R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: Clinical experience of the first thirty-one patients. Acta Oncol 1995;34:861–70.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Heilman K, Wulf J, Mueller G, Beckmann G, Flentje M. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): Results of a serial follow-up CT study. Radiother Oncol 2007;85:435–42.
   PubMed Web of Science ®Google Scholar
• Kimura T, Matsuura K, Murakami Y, Hashimoto Y, Kenjo M, Kaneyasu Y, . CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: Are patients with pulmonary emphysema also candidates for SBRT for lung cancers? Int J Radiat Oncol Biol Phys 2006;66: 483–91.
   PubMed Web of Science ®Google Scholar
• Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer – a systematic review. Radiother Oncol 2004;71:127–38.
   PubMed Web of Science ®Google Scholar
• Borst GR, Shirato H, Nijkamp J, Onimaru R, Ishikawa M, Lebesque JV, Sonke J. Radiation pneumonitis for stereotactic irradiated lung cancer patients: Is the LQ model valid for high doses per fraction? Int J Radiat Oncol Biol Phys 2008; 72(1Suppl. 1):S68–69.
   Google Scholar
• Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 2008;18:234–9.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 2008;18:240–3.
   PubMed Web of Science ®Google Scholar
• Fowler JF. Linear quadratics is alive and well: In regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847–52). Int J Radiat Oncol Biol Phys 2008;72:957.
   PubMed Web of Science ®Google Scholar
• Park C, Papiez L, Timmerman RD. In reply to Dr. Fowler and Dr. Kavanagh. Int J Radiat Oncol Biol Phys 2008; 72:958.
   PubMedGoogle Scholar
• Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:847–52.
   PubMed Web of Science ®Google Scholar
• Borst GR, Ishikawa M, Nijkamp J, Hauptmann M, Shirato H, Bengua G, . Radiation pneumonitis after hypo-fractionated radiotherapy: Evaluation of the lq(l) model and different dose parameters. Int J Radiat Oncol Biol Phys 2010 Epub 2010 Mar 16.
   Google Scholar
• Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2001;49:23–33.
   PubMed Web of Science ®Google Scholar
• Thames H, Hendry J. Fractionation in radiotherapy. Thames H, Hendry J. London: Taylor and Francis; 1987.
   Google Scholar
• Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, . Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – a first report of toxicity related to COPD/CVD in a prospective phase II study. Radiother Oncol 2008;88:359–67.
   PubMed Web of Science ®Google Scholar
• Panettieri V, Wennberg B, Gagliardi G, Duch MA, Ginjaume M, Lax I. SBRT of lung tumours: Monte Carlo simulation with PENELOPE of dose distributions including respiratory motion and comparison with different treatment planning systems. Phys Med Biol 2007;52:4265–81.
   PubMed Web of Science ®Google Scholar
• Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys 1989; 16:1623–30.
   PubMed Web of Science ®Google Scholar
• Lyman JT. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 1985;8:S13–19.
   PubMedGoogle Scholar
• Martel MK, Ten Haken RK, Hazuka MB. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 1994;28:575–81.
   PubMedGoogle Scholar
• Burman C, Kutcher GJ, Emami B. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991;21:123–35.
   PubMed Web of Science ®Google Scholar
• Lax I, Karlsson B. Prediction of complications in Gamma-Knife radiosurgery of arteriovenous malformations. Acta Oncol 1996;35:49–55.
   PubMed Web of Science ®Google Scholar
• Song D, Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, . Stereotactic body radiation therapy of lung tumors: Preliminary experience using normal tissue complication probability-based dose limits. Am J Clin Oncol 2005; 28:591–6.
   PubMed Web of Science ®Google Scholar
• Schefter TE, Kavanagh BD, Raben D, Kane M, Chen C, Stuhr K, . A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity. Int J Radiat Oncol Biol Phys 2006;66(4 Suppl 1):S120–7.
   Google Scholar
• Hoyer M, Roed H, Traberg Hansen A, Ohlhuis L, Petersen J, Nellemann H. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;66(4 Suppl 1):S128–35.
   Google Scholar
• Paludan M, Traberg Hansen A, Petersen J, Grau C, Hoyer M. Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? Acta Oncol 2006;45:818–22.
   PubMed Web of Science ®Google Scholar
• Nyman J, Johansson K-A, Hulten U. Stereotactic hypo-fractionated radiotherapy for stage I non-small cell lung cancer – Mature results for medically inoperable patients. Lung Cancer 2006;51:97–103.
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186–96.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, . Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–31.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Nakagawa K, Nakamura N, Koyanagi H, Tago M, Igaki H, . Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007;2:21.
   PubMedGoogle Scholar
• Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, . Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: Patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Lung Cancer 2004;45:45–55.
   PubMed Web of Science ®Google Scholar
• Borst GR, Ishikawa M, Nijkamp J, Hauptmann M, Shirato H, Onimaru R, . Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypo fractionated radiation therapy. Radiother Oncol 2009; 91:307–13.
   PubMed Web of Science ®Google Scholar
• Seppenwoolde Y, De Jaeger K, Boersma LJ, Belderbos JSA, Lebesque JV. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004;60:748–58.
   PubMedGoogle Scholar
• Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Mantovani C, Fiandra C, . Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy. Acta Oncol 2009;48:571–7.
   PubMed Web of Science ®Google Scholar
• Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JSA, Boersma LJ, Schilstra C, . Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2003;55:724–35.
   PubMed Web of Science ®Google Scholar
• Semenenko VA, Molthen RC, Li C, Morrow NV, Li R, Ghosh SN, . Irradiation of varying volumes of rat lung to same mean lung dose: A little to a lot or a lot to a little? Int J Radiat Oncol Biol Phys 2008;71:838–47.
   PubMed Web of Science ®Google Scholar
• Oetzel D, Schraube P, Hensley F, Sroka-Perez G, Menke M, Flentje F. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 1995;33: 455–60.
   PubMedGoogle Scholar
• Yorke ED, Jackson A, Rosenzweig KE, Merrick SA, Gabrys D, Venkatraman ES, . Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 2002;54: 329–39.
   PubMed Web of Science ®Google Scholar
• Wennberg B, Gagliardi G, Sundbom L, Svane G, Lind P. Early response of lung in breast cancer irradiation: Radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 2002;52:1196–206.
   PubMed Web of Science ®Google Scholar
• De Jaeger K, Hoogeman MS, Engelsman M, Seppenwoolde Y, Damen E, Mijnheer B, . Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: Re-evaluation of dose in normal lung tissue. Radiother Oncol 2003;69:1–10.
   PubMedGoogle Scholar